Equity Investment and Acquisition of WatchChild®

Healthcare
Equity Investment and Acquisition of WatchChild®

Summary

Baird served as the exclusive financial advisor to PeriGen, Inc. on this transaction

About

PeriGen, Inc. (“PeriGen” or the “Company”), a portfolio company of Trident Capital (“Trident”) and Galen Partners (“Galen”), has acquired the WatchChild® Fetal Monitoring System (“WatchChild”) from Hill-Rom Holdings, Inc. (“Hill-Rom”) (NYSE:HRC). In conjunction with the WatchChild acquisition, PeriGen closed an investment round led by Atalaya Capital Management (“Atalaya”) and Ambina Partners LTD (“Ambina”). Terms of the transaction were not disclosed.

PeriGen offers innovative perinatal software solutions that incorporate artificial intelligence features to enhance clinical efficiency and standardization of care during childbirth. Led by skilled obstetrics practitioners and healthcare technology (HCIT) professionals, PeriGen has created the PeriCALM™ platform to provide consistent analysis and efficient display of complex data in real-time to promote better human recognition and communication about impending problems during labor. PeriGen is headquartered in Princeton, New Jersey.

Trident is a growth equity investor focused on enterprise software and services, internet and mobility, HCIT and cybersecurity. Founded in 1993 and with $1.9 billion under management, Trident invests across North America in both control and lead investments. Trident is based in Palo Alto, California.

Galen is a healthcare growth equity firm that focuses on investments in HCIT-enabled services, medical devices and specialty pharmaceutical companies. Galen has invested nearly $1 billion of capital in more than 70 companies since 1990. Galen leads investments of $10 million to $30 million of growth equity capital. Galen is based in Stamford, Connecticut.

WatchChild is a comprehensive, evidence-based perinatal data management and clinical decision support system. WatchChild was developed based upon National Institute of Child Health and Human Development guidelines to simplify the process of managing information throughout the labor and delivery process. WatchChild is based in Cary, North Carolina.

Hill-Rom is a leading global medical technology company with 10,000 employees worldwide. Hill-Rom partners with healthcare providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency and Respiratory Health. Hill-Rom is headquartered in Chicago, Illinois.

Atalaya is an advisory firm focused on making opportunistic credit and special situations investments. Since inception, Atalaya has invested over $2 billion through the purchase of loans and credit assets, and proprietary credit originations, including a wide variety of financings. Atalaya is headquartered in New York, New York.

Ambina is a private investment firm focused on investing in software and financial services companies. Ambina is based in New York, New York.

For additional information about this transaction, please contact:

Bill Suddath +1 (404) 264-2222
Nick Anderson +1 (312) 609-7061
Vincenzo di Nicola +44 (0) 207 667 8532
Healthcare
Equity Investment and Acquisition of WatchChild®
Date
September 2016
Company
PeriGen, Inc.
Transaction
M&A
Sectors
Healthcare
Target Location
North America
Acquiror Location
North America

Share